A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use

计划入组 60 人 · 首次发布于 2024 年 12 月 10 日

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

计划入组 904 人 · 首次发布于 2023 年 7 月 3 日

Remifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality

计划入组 88 人 · 首次发布于 2026 年 9 月 2 日

abuse deterring opioids-1

abuse deterring opioids-2

Synthetic camphor(Anbesol Cold Sore Therapy, Flexall Ultra Plus, Icy Hot Arthritis, Ivy-dry Cream, Jointflex, Men-phor, Ortho-nesic, Salonpas Pain Relieving Patch, Sarna Sensitive, Tiger Balm, Vaporex, Vicks Vaporub, Vicks Vaposteam)

C₁₀H₁₆O

SYNTHETIC BIOLOGICS INC

United States

DELTA SYNTHETIC CO., LTD.

Taiwan

New Leaf Partners

United States

Welsh Drug Testing Programme Identifies Powerful New Synthetic Opioids, Revealing an Increasingly Unpredictable Illicit Drug Market

New Health Risks Emerge as Europe's Drug Market Grows More Complex, EU Agency Warns

Ohio Issues Public Safety Warning on Orphine Analogs and Veterinary Sedatives in Drug Supply